Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 10-week, Randomized, Double-Blind, Placebo-Controlled Trial of a Neurocognition Enhancing Agent(Pregnenolone) in Patients With Schizophrenia.

NCT00894842 is registered in ClinicalTrials.gov with National Research Foundation, Singapore as lead sponsor.

NCT NCT00894842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00894842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 10-week, Randomized, Double-Blind, Placebo-Controlled Trial of a Neurocognition Enhancing Agent(Pregnenolone) in Patients With Schizophrenia.
Lead sponsor
National Research Foundation, Singapore
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2009
Completion date
September 30, 2011
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia